PHILIP H. COELHO

Software Technology Evidence

8 mention(s) identify PHILIP H. COELHO as having software/technology expertise.

Company	Filing Date	Evidence	Reason
CATALYST PHARMACEUTICALS, INC.	2013-04-15	Mr. Coelho was Chairman and Chief Executive Officer of ThermoGenesis from December 1989 until May 2007 and served as its Chief Technology Architect from June 2007 until May 2008.	Held position of Chief Technology Architect at ThermoGenesis Corp., a company focused on blood processing and hospital/woundcare markets, indicating technical and software-related skills.
CATALYST PHARMACEUTICALS, INC.	2016-04-29	Mr. Coelho is currently Co-Founder and Chief Technology Officer of SynGen, Inc., a company enabling regenerative cures through the application of innovative engineering... Mr. Coelho was Chairman and Chief Executive Officer of ThermoGenesis from December 1989 until May 2007 and served as its Chief Technology Architect from June 2007 until May 2008.	He is Co-Founder and Chief Technology Officer of SynGen, Inc., and was Chief Technology Architect at ThermoGenesis Corp., indicating technical expertise likely including software-related skills.
CATALYST PHARMACEUTICALS, INC.	2017-04-14	Philip H. Coelho has been a member of our Board of Directors since October 2002 and currently chairs the Nominating & Corporate Governance Committee of our Board. Mr. Coelho is currently Co-Founder and Chief Technology Officer of SynGen, Inc. a company enabling regenerative cures through the application of innovative engineering and President of PHC Medical, Inc., a company providing consulting services for enterprises in the medical device related cell therapy field. Previously, from October 1986 until 2008, Mr. Coelho founded and was employed by ThermoGenesis Corp. (n/k/a CESCA Therapeutics Inc.), a company focused on the blood processing and hospital/woundcare markets. Mr. Coelho was Chairman and Chief Executive Officer of ThermoGenesis from December 1989 until May 2007 and served as its Chief Technology Architect from June 2007 until May 2008. From October 1986 to September 1989, Mr. Coelho held the position of Vice President and Director of Research, Development and Manufacturing with ThermoGenesis. Prior to his association with ThermoGenesis, from October 1983 to October 1986 Mr. Coelho was President of Castleton, Inc., a company that developed and licensed ultra-rapid heat transfer technology to ThermoGenesis. Mr. Coelho currently serves on the Board of Directors of Mediware Information Systems, Inc. and Ampio Pharmaceuticals, Inc. Mr. Coelho holds a Bachelor of Science degree in Mechanical Engineering from the University of California, Davis.	Co-Founder and Chief Technology Officer of SynGen, Inc., and Chief Technology Architect of ThermoGenesis Corp., indicating technical and software-related expertise. Holds a Bachelor of Science degree in Mechanical Engineering.
CATALYST PHARMACEUTICALS, INC.	2018-04-17	Mr. Coelho is currently Chief Technology Officer of ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics, a leading regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics. ... Mr. Coelho holds a Bachelor of Science degree in Mechanical Engineering from the University of California, Davis.	Has a Bachelor of Science degree in Mechanical Engineering and extensive experience as Chief Technology Officer and Chief Technology Architect at technology-focused companies, indicating technical and software-related skills.
CATALYST PHARMACEUTICALS, INC.	2019-04-18	Mr. Coelho is currently Chief Technology Officer of ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics, a leading regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics. Mr. Coelho was Chairman and Chief Executive Officer of ThermoGenesis from December 1989 until May 2007 and served as its Chief Technology Architect from June 2007 until May 2008. Mr. Coelho holds a Bachelor of Science degree in Mechanical Engineering from the University of California, Davis.	Has experience as Chief Technology Officer at ThermoGenesis Corp., a company providing automated technologies, and was Chief Technology Architect. Holds a Bachelor of Science degree in Mechanical Engineering.
CATALYST PHARMACEUTICALS, INC.	2020-07-07	Mr. Coelho is currently Chief Technology Officer of ThermoGenesis Corp., a wholly owned subsidiary of Thermogenesis Holdings, Inc, a leading regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics... Mr. Coelho holds a Bachelor of Science degree in Mechanical Engineering from the University of California, Davis.	Has been Chief Technology Officer of ThermoGenesis Corp., a company providing automated technologies for cell-based therapeutics, and has a Bachelor of Science degree in Mechanical Engineering. His roles involved technology and engineering, indicating technical skills relevant to software or adjacent fields.
CATALYST PHARMACEUTICALS, INC.	2021-10-26	Mr. Coelho is currently Chief Technology Officer of ThermoGenesis Corp., a wholly owned subsidiary of Thermogenesis Holdings, Inc, a leading regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics. ThermoGenesis Corp. provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for the preparation of immuno-oncology drugs. Until July 2017, Mr. Coelho served as Co-Founder and Chief Technology Officer of SynGen, Inc. a company enabling regenerative cures through the application of innovative engineering and President of PHC Medical, Inc., a company providing consulting services for enterprises in the medical device related cell therapy field.	Has extensive experience as Chief Technology Officer and Chief Technology Architect at ThermoGenesis Corp., a company providing automated technologies, indicating technical and software-related skills.
CATALYST PHARMACEUTICALS, INC.	2022-08-05	Mr. Coelho was Chief Technology Officer of ThermoGenesis Corp., a wholly owned subsidiary of Thermogenesis Holdings, Inc, a leading regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics from July 2017 until his resignation in February 2022. Mr. Coelho served as Co-Founder and Chief Technology Officer of SynGen, Inc. a company enabling regenerative cures through the application of innovative engineering and President of PHC Medical, Inc., a company providing consulting services for enterprises in the medical device related cell therapy field.	Has held Chief Technology Officer roles and was involved in technology and engineering in regenerative medicine and medical device fields, indicating software-related technical skills.